Literature DB >> 34813352

Genetic Regulation of RIPK1 and Necroptosis.

Daichao Xu1, Chengyu Zou1, Junying Yuan1.   

Abstract

The receptor-interacting protein kinase 1 (RIPK1) is recognized as a master upstream regulator that controls cell survival and inflammatory signaling as well as multiple cell death pathways, including apoptosis and necroptosis. The activation of RIPK1 kinase is extensively modulated by ubiquitination and phosphorylation, which are mediated by multiple factors that also control the activation of the NF-κB pathway. We discuss current findings regarding the genetic modulation of RIPK1 that controls its activation and interaction with downstream mediators, such as caspase-8 and RIPK3, to promote apoptosis and necroptosis. We also address genetic autoinflammatory human conditions that involve abnormal activation of RIPK1. Leveraging these new genetic and mechanistic insights, we postulate how an improved understanding of RIPK1 biology may support the development of therapeutics that target RIPK1 for the treatment of human inflammatory and neurodegenerative diseases.

Entities:  

Keywords:  MLKL; RIPK1; RIPK3; TNFR1; apoptosis; inflammation; necroptosis; neurodegeneration

Mesh:

Substances:

Year:  2021        PMID: 34813352     DOI: 10.1146/annurev-genet-071719-022748

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  3 in total

Review 1.  Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.

Authors:  Chunmei Zhang; Ning Liu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

2.  PP6 negatively modulates LUBAC-mediated M1-ubiquitination of RIPK1 and c-FLIPL to promote TNFα-mediated cell death.

Authors:  Guowei Wu; Dekang Li; Wei Liang; Weimin Sun; Xingxing Xie; Yilun Tong; Bing Shan; Mengmeng Zhang; Xiaojuan Lu; Junying Yuan; Ying Li
Journal:  Cell Death Dis       Date:  2022-09-07       Impact factor: 9.685

3.  A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes.

Authors:  Qiangmin Qiu; Yanze Li; Ye Zhang; Yanguang Hou; Juncheng Hu; Lei Wang; Zhiyuan Chen; Yourong Lei; Yang Du; Xiuheng Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.